Adlai Nortye Ltd. (ANL)
NASDAQ: ANL · Real-Time Price · USD
13.84
+0.77 (5.89%)
Aug 6, 2026, 4:00 PM EDT - Market closed
Adlai Nortye Market Cap
Adlai Nortye has a market cap or net worth of $553.6 million as of August 7, 2026. Its market cap has increased by 900.18% in one year.
Market Cap
553.60M
Enterprise Value
571.02M
1-Year Change
900.18%
Ranking
Category
Stock Price
$13.84
ChartMarket Cap Chart
Since the IPO on September 29, 2023, Adlai Nortye's market cap has increased from $553.50M to $553.60M, an increase of 0.02%. That is a compound annual growth rate of 0.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 553.60M | 956.53% |
| Dec 31, 2025 | 52.40M | -47.12% |
| Dec 31, 2024 | 99.08M | -70.13% |
| Dec 29, 2023 | 331.73M | -40.07% |
| Sep 29, 2023 | 553.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Arvinas | 551.53M |
| Shattuck Labs | 548.65M |
| 4D Molecular Therapeutics | 541.06M |
| ARS Pharmaceuticals | 539.22M |
| Silence Therapeutics | 537.05M |
| Zura Bio | 536.26M |
| Prime Medicine | 529.21M |
| Sagimet Biosciences | 522.42M |